Literature DB >> 25973035

Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.

Nermeen S Youssef1, Wesam M Osman1.   

Abstract

Previous studies on the prognostic value of osteopontin (OPN) and β-catenin in colorectal carcinoma (CRC) revealed conflicting results. To date, only two immunohistochemical studies investigated their association in CRC with discrepant results. Moreover, the relevance of their co-expression to clinicopathological parameters was not previously reported. This study was designed to investigate the relationship between these markers and prognostic parameters in CRC and study further the relationship between them. Immunohistochemical expression of OPN and β-catenin was evaluated in 72 CRCs. Cytoplasmic OPN was detected in 45.83% of CRCs while normal mucosa was immunonegative. Strong continuous membranous β-catenin was present in normal mucosa. However, abnormal membranous, nuclear and cytoplasmic expressions were observed in 36.11%, 31.94% and 52.78% of CRCs, respectively. A highly significant relationship was detected between each of OPN and nuclear β-catenin expression and lymph node metastasis (P = 0.0001 and 0.004 respectively), depth of invasion (P = 0.001 and 0.004 respectively), TNM stages (P = 0.0001 and 0.001 respectively) and Dukes' stages (P = 0.0001 and 0.004 respectively). A significant association was found between OPN and distant metastases. A strong agreement was observed between OPN and nuclear β-catenin (kappa = 0.656). A highly significant relationship was found between their co-expression and poor prognostic parameters. OPN overexpression and nuclear β-catenin expression appeared to be associated with unfavorable prognostic factors in CRC. A direct relationship was observed between them. Further understanding their role in colorectal carcinogenesis as well as targeting the interaction between them might be effective in the future development of therapeutic agents for CRC patients.

Entities:  

Keywords:  Colorectal carcinoma; immunohistochemistry; osteopontin; β-catenin

Mesh:

Substances:

Year:  2015        PMID: 25973035      PMCID: PMC4396305     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  49 in total

1.  Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.

Authors:  K Maruyama; A Ochiai; S Akimoto; S Nakamura; S Baba; Y Moriya; S Hirohashi
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.

Authors:  M Fujimori; S Ikeda; Y Shimizu; M Okajima; T Asahara
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

Authors:  Deepak Agrawal; Tingan Chen; Rosalyn Irby; John Quackenbush; Ann F Chambers; Marianna Szabo; Alan Cantor; Domenico Coppola; Timothy J Yeatman
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

Review 5.  Osteopontin as a target for cancer therapy.

Authors:  Nicholas I F Johnston; Vignesh Kumar Gunasekharan; Amod Ravindranath; Ciara O'Connell; Patrick G Johnston; Mohamed K El-Tanani
Journal:  Front Biosci       Date:  2008-05-01

6.  Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.

Authors:  Jiasen Cheng; De-Hua Huo; Dong-Ming Kuang; Jine Yang; Limin Zheng; Shi-Mei Zhuang
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

7.  Assembly of the cadherin-catenin complex in vitro with recombinant proteins.

Authors:  H Aberle; S Butz; J Stappert; H Weissig; R Kemler; H Hoschuetzky
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

8.  Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

Authors:  Aleksandra Stanczak; Rafal Stec; Lubomir Bodnar; Wojciech Olszewski; Marzena Cichowicz; Wojciech Kozlowski; Cezary Szczylik; Tadeusz Pietrucha; Maciej Wieczorek; Monika Lamparska-Przybysz
Journal:  Pathol Oncol Res       Date:  2011-06-16       Impact factor: 3.201

9.  β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.

Authors:  Zhigang Chen; Xin He; Minyue Jia; Yang Liu; Dihong Qu; Dang Wu; Pin Wu; Chao Ni; Zhigang Zhang; Jun Ye; Jinghong Xu; Jian Huang
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

10.  Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.

Authors:  Jianjin Huang; Chi Pan; Hanguang Hu; Shu Zheng; Ling Ding
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more
  5 in total

1.  Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression.

Authors:  Nanhui Yu; Hong Zhu; Yiming Tao; Yongpan Huang; Xiangping Song; Yuan Zhou; Yuqiang Li; Qian Pei; Qiurong Tan; Haiping Pei
Journal:  Onco Targets Ther       Date:  2016-10-28       Impact factor: 4.147

Review 2.  Tumor microenvironment involvement in colorectal cancer progression via Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistance.

Authors:  María Belén Novoa Díaz; María Julia Martín; Claudia Gentili
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

3.  Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Hongfeng Yan; Fuquan Jiang; Jianwu Yang
Journal:  Genet Res (Camb)       Date:  2022-08-17       Impact factor: 1.375

4.  A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.

Authors:  Jian-Hong Peng; Yu-Jing Fang; Cai-Xia Li; Qing-Jian Ou; Wu Jiang; Shi-Xun Lu; Zhen-Hai Lu; Pei-Xing Li; Jing-Ping Yun; Rong-Xin Zhang; Zhi-Zhong Pan; De Sen Wan
Journal:  Oncotarget       Date:  2016-04-19

5.  Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis.

Authors:  Shizhen Zhang; Zhen Wang; Jinlan Shan; Xiuyan Yu; Ling Li; Rui Lei; Daozhe Lin; Siqi Guan; Xiaochen Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.